Clinical Trial Update: Rabbit Antithymocyte Globulin Versus Campath-1H for Treating Severe Aplastic Anemia [Phase 2]

View source ↗

Summary

Phase 2 trial comparing Rabbit Antithymocyte Globulin to Campath-1H for severe aplastic anemia; study completed with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia

Drugs mentioned

• Campath-1H (alemtuzumab)
• rabbit antithymocyte globulin (rabbit antithymocyte globulin)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Aplastic Anemia | Phase 2 | Status: COMPLETED | Results posted: 2016-03-03